Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Clal Biotechnology Industries's Days Payable or its related term are showing as below:
During the past 13 years, Clal Biotechnology Industries's highest Days Payable was 192.27. The lowest was 77.76. And the median was 91.62.
XTAE:CBI's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 112.83 * Ranked among companies with meaningful Days Payable only.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTAE:CBI vs VRTX, REGN, RVMD: Days Payable Comparison
For the Biotechnology subindustry, Clal Biotechnology Industries's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clal Biotechnology Industries Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Clal Biotechnology Industries's Days Payable distribution charts can be found below:
* The bar in red indicates where Clal Biotechnology Industries's Days Payable falls into.
Clal Biotechnology Industries Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clal Biotechnology Industries (XTAE:CBI) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Clal Biotechnology Industries and its competitors. Over the past decade, Clal Biotechnology Industries' Days Payable has ranged from 77.76 to 192.27. According to the industry distribution chart, Clal Biotechnology Industries ranks #999999 out of 704 companies in the Biotechnology industry.
Is Clal Biotechnology Industries' Days Payable too high?
Clal Biotechnology Industries' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 77.76 to a high of 192.27. Based on the distribution chart, Clal Biotechnology Industries ranks #999999 out of 704 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Clal Biotechnology Industries has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Clal Biotechnology Industries' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Clal Biotechnology Industries ranks #999999 out of 704 companies for Days Payable. This places Clal Biotechnology Industries in the lower half of its industry. The industry median Days Payable is 112.83. Historically, Clal Biotechnology Industries' own Days Payable has ranged from 77.76 to 192.27 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.83, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Clal Biotechnology Industries and its competitors. For the Biotechnology industry, the median Days Payable is 112.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clal Biotechnology Industries's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clal Biotechnology Industries stock overvalued right now?
Clal Biotechnology Industries (XTAE:CBI) has a current Days Payable of 0.00. The current Days Payable is 0.00. Clal Biotechnology Industries' overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Clal Biotechnology Industries (XTAE:CBI), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.
18GF Score
Get the complete analysis for XTAE:CBI
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:CBI has been successfully added to your 
